Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D08DZO
|
|||
| Former ID |
DNCL003241
|
|||
| Drug Name |
Malaria DNA vaccine
|
|||
| Indication | Malaria [ICD-11: 1F40-1F45; ICD-10: B50-B64, B54] | Phase 1/2 | [1] | |
| Company |
U.S. Naval Medical Research Center; Vical
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Clinical trial in healthy malaria-na ve adults to evaluate the safety, tolerability, immunogenicity and efficacy of MuStDO5, a five-gene, sporozoite/hepatic stage Plasmodium falciparum DNA vaccine combined with escalating dose human GM-CSF DNA. Hum Vaccin Immunother. 2012 November 1; 8(11): 1564-1584. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.